Manufacturer record
National Pharmacetutical G-18/1: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by National Pharmacetutical G-18/1 (Maharashtra) was declared Not of Standard Quality in December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 63, New unsyn Tablets Acetyl Salicyclic Acid BP 150mg Paracetamol BP 150mg, Caffeine (Anhydrous) BP 25mg Tablets (exp Jul 2026). FDAL, Mumbai (state lab) found it not of standard quality: Description. Listed in the December 2025 alert.
Records by type
1 record linked to National Pharmacetutical G-18/1 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| New unsyn Tablets Acetyl Salicyclic Acid BP 150mg Paracetamol BP 150mg, Caffeine (Anhydrous) BP 25mg Tablets | Batch 63Mfg Aug 2023 · Exp Jul 2026 | DescriptionDescription | FDAL, MumbaiState lab | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.